Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-14607-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Androgen Receptor-Positive, Triple-Negative Breast Cancer

Cancer
Cancer ResearchOncology
2017English

Prohibitin Promotes Androgen Receptor Activation in ER-positive Breast Cancer

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2017English

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2019English

Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2018English

The Androgen Receptor in Breast Cancer

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Increased Mortality in HER2 Positive, Oestrogen Receptor Positive Invasive Breast Cancer: A Population-Based Study

British Journal of Cancer
Cancer ResearchOncology
2010English

Androgen Receptor in Male Breast Cancer

Polish Journal of Pathology
MedicineForensic MedicinePathology
2015English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

BCL11A Confers Cell Invasion and Migration in Androgen Receptor‑positive Triple‑negative Breast Cancer

Oncology Letters
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy